Retatrutide (LY3437943, also referred to informally as "reta peptide") is a synthetic 39-amino-acid peptide developed by Eli Lilly that acts simultaneously on three distinct metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
It serves as an advanced tool for investigating incretin biology and multi-hormonal metabolic pathways
When back pain, tingling, or stabbing discomfort affect your quality of life, you need specialized medical support
The decision often depends on the specific research goals and the individual immune profile being studied
Use a new sterile syringe and needle for each injection
From non-surgical treatments like skin tightening and injectables that restore youthful volume, to surgical solutions for removing excess skin or sculpting your body, we carefully design each plan with your goals and lifestyle in mind